Community Collaboration to Combat COVID-19 (C-FORWARD)

NACompletedINTERVENTIONAL
Enrollment

831

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

June 9, 2023

Study Completion Date

June 9, 2023

Conditions
Coronavirus Infection
Interventions
BEHAVIORAL

Fixed site standard of care testing

This arm includes all three Johns Hopkins (JHMI) ambulatory outdoor testing sites across Baltimore City. Each site represents a traditional appointment-based scheduling system. Participants will be given a choice of 1 of 3 outdoor testing locations based on their preferences. Study staff will make an appointment for testing based on testing availability and participant schedule.

BEHAVIORAL

Community-based, mobile van testing

This arm offers the convenience of highly accessible testing and with the flexibility of no fixed appointment time. Each of the 12 geographic strata will have a single, centrally located testing site within the area, providing similar geographic access across households. The testing location will be published on the study website and social media so that participants can visit the location at a time convenient to them.

BEHAVIORAL

Self-collected, home-based testing

Individuals will receive a home-based testing kit delivered by a courier service as soon as the randomization of the household is complete. The kit will include provisions for contacting the courier service for pick up. Appropriate biohazard precautions are included. Each of the testing components of this kit will include FDA Emergency Use Authorization approved collection methods. Easy to use instructions with options to view pre-recorded videos and/or virtual 'on demand' coaching sessions with members of the study team via a HIPAA-secure Zoom session will be available.

Trial Locations (1)

21205

2212 McElderry Street, Baltimore

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Johns Hopkins University

OTHER

NCT04673292 - Community Collaboration to Combat COVID-19 (C-FORWARD) | Biotech Hunter | Biotech Hunter